免疫检查点抑制剂在宫癌和子宫内膜癌中的演变作用
Bertha Alejandra Martinez-Cannon1, Ilaria Colombo2
1Hematology-Oncology Department, National Institute of Medical Sciences and Nutrition Salvador Zubiran, Mexico City 14080, Mexico.
Cancer drug resistance (Alhambra, Calif.)
|July 25, 2024
概括
免疫检查点抑制剂 (ICI) 对宫癌和子宫内膜癌具有前景,但耐药性限制了有效性. 本综述探讨了ICI机制和这些妇科恶性瘤的耐药性.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 妇科癌症 妇科癌症
背景情况:
- 针对PD-1,PD-L1和CTLA-4的免疫检查点抑制剂 (ICI) 已经改变了癌症治疗.
- 在晚期宫癌和子宫内膜癌中,ICI已经显示出显著的疗效.
研究的目的:
- 审查ICI在宫癌和子宫内膜癌的合理性和当前应用.
- 确定这些癌症中对ICI的内在和适应性耐药性的机制.
主要方法:
- 临床研究和关于ICI在宫癌和子宫内膜癌的研究的文献综述.
- 分析已批准的ICI治疗方法和新兴的治疗策略.
- 探索对免疫疗法提出的抗药性机制.
主要成果:
- ICI已被批准用于宫癌和子宫内膜癌的不同阶段,改善反应率和存活率.
- 特定的ICI如pembrolizumab,cemiplimab,nivolumab,atezolizumab和 dostarlimab在不同的治疗环境中使用.
- 尽管取得了成功,但很大一部分患者由于耐药性而没有受益.
结论:
- ICI代表了治疗宫癌和子宫内膜癌的重大进展.
- 了解和克服ICI耐药性对于改善患者的治疗结果至关重要.
- 对抗性机制的进一步研究将指导未来的治疗开发.
相关概念视频
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
01:27Tumor Immunotherapy
501
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
501
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:30Cancer Vaccines
348
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
348
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K